Because MORT is an ETF, brokerage analysts do not issue price targets on the fund itself. Instead, they focus on the underlying mortgage REITs. A weighted average of those holding-level targets, as compiled by MarketBeat, aligned roughly with the fund’s price in early November 2026. That provided context but not a direct objective for the ETF.
The $9 figure therefore rests on technical levels that have appeared in public market discussion. MORT traded much of 2026 between roughly $9 and $10 before a sharp late-year drop took it toward $7. Reclaiming the $9 area, a former support zone that broke down, stands as a realistic recovery milestone and sits about 29% above recent prices. It remains a technical reference point rather than a forecast.
MORT recently traded around $7.00, with closes near $7.18 in mid-November and near $6.96 by late November as it approached its 52-week low of $6.80. The 52-week high of $11.44 shows how far the sector has declined. Reaching $9 would require an advance of roughly 29%, recovering about half the drop from the highs.
The path hinges mainly on the mortgage REIT sector. These companies borrow short-term and invest in mortgage-backed securities, so their net interest margins and book values respond sharply to Federal Reserve policy, yield-curve shape, and credit conditions. Stabilization in rates or narrower mortgage spreads could support book values and, in turn, the ETF’s price. I also checked this using Tickeron’s AI Screener to see how the fund compares with peers in the sector.
The $7.00 area and the 52-week low near $6.80 mark the nearest support levels; a decisive break below them would leave the fund in new territory for the year. On the upside, the $9.00 target coincides with a former support zone that turned into resistance after the late-year breakdown, making it a meaningful technical milestone. Above that, $10 and $11.44 represent progressively larger recovery levels. The persistent decline through the second half of 2026 has established a clear downtrend that would need to reverse before any sustained move toward $9 could develop.
Technical recovery objectives such as $9 do not carry a defined time horizon. Investors should instead track the factors most likely to influence the fund over coming quarters: Federal Reserve rate decisions, Treasury yield movements, mortgage spread trends, and quarterly earnings and book-value updates from Annaly, AGNC, and other top holdings. Dividend declarations and fund-flow shifts also warrant attention, as mREIT payouts can adjust with earnings pressure. None of these observations constitutes a forecast.
I find AI Daily Buy/Sell Signals helpful for monitoring funds like MORT. The system uses artificial intelligence to scan thousands of stocks and ETFs continuously, generating Buy, Sell, or Hold signals based on technical behavior and market conditions. It synthesizes multiple inputs rather than relying on a single metric, which can help surface potential turning points in a volatile, rate-sensitive fund more efficiently.
Whether MORT can reach $9 depends on the path of interest rates and the broader health of the mortgage REIT sector. The $9 objective is a technical recovery milestone, not an analyst consensus, and it sits roughly 29% above recent prices near $7.00. Supporting factors include the high distribution yield, discounted book values among holdings, and the possibility of rate stability. Countering those are ongoing rate pressure, credit risk, and a concentrated portfolio that has already surrendered much of its 2026 gains. Watching Fed policy, mortgage spreads, and book-value trends remains essential, and no outcome is assured.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The Aroon Indicator for MORT entered a downward trend on October 28, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 213 similar instances where the Aroon Indicator formed such a pattern. In 191 of the 213 cases the stock moved lower. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MORT as a result. In 75 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for MORT turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 37 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where MORT advanced for three days, in 242 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
MORT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows